Bristol Myers Squibb Co (BMY) Curent Deferred Tax Liability (2009 - 2012)

Bristol Myers Squibb (BMY) has reported Curent Deferred Tax Liability for 4 consecutive years, with -$10.0 million the latest figure, recorded in Q4 2012.

• In Q4 2012, Curent Deferred Tax Liability fell 66.67% year-over-year to -$10.0 million; the TTM figure through Dec 2012 stood at -$10.0 million (down 66.67% YoY), while the FY2012 annual figure was -$10.0 million, down 66.67% from the prior year.
• Curent Deferred Tax Liability fell to -$10.0 million in Q4 2012 per BMY's latest filing, from -$6.0 million in the prior quarter.
• Across five years, Curent Deferred Tax Liability topped out at $8.0 million in Q4 2009 and bottomed at -$10.0 million in Q4 2012.
• Historically, Curent Deferred Tax Liability has averaged -$3.2 million across 4 years, with a median of -$5.5 million in 2010.
• Annual changes were most pronounced in 2010 — Curent Deferred Tax Liability plunged 162.5% — and 2011, when it dropped 20.0%.
• Bristol Myers Squibb's Curent Deferred Tax Liability stood at $8.0 million in 2009, then slumped by 162.5% to -$5.0 million in 2010, then slipped by 20.0% to -$6.0 million in 2011, then slumped by 66.67% to -$10.0 million in 2012.
• Business Quant data shows BMY's Curent Deferred Tax Liability at -$10.0 million in Q4 2012, -$6.0 million in Q4 2011, and -$5.0 million in Q4 2010.